Biosante Pharmaceuticals, Inc. (BPAX) Stock Ratings


View Stock Quote:

BPAX

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Not Rated

No Current Ratings

View All-Time Ratings

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
myrooz 03/01/2012 3 months $0.77 $0.50 -35.12% -35 Ended
Comments: Upcoming product launch will be successful
LakeshaToole 02/28/2012 3 months $0.81 $0.52 -35.94% -35 Ended
Comments: Industry sector growing or poised for growth
InvestorVirg_2 02/26/2012 3 months $0.71 $0.52 -26.76% -26 Ended
Comments: Industry sector growing or poised for growth
huptus 02/24/2012 1 month $0.73 $1.60 +118.43% 118 Ended
Comments: This stock is undervalued
m4KiNUs3 02/21/2012 3 months $0.71 $0.34 -52.32% -52 Ended
Comments: Industry sector growing or poised for growth
kylejwarren1 02/16/2012 3 months $0.83 $0.40 -51.78% -51 Ended
Comments: Projecting strong long-term growth
NextBuffett 02/03/2012 1 Year $0.71 $1.45 +105.67% 105 Ended
Comments: This stock is undervalued
Cheez 01/12/2012 3 months $0.51 $1.60 +212.5% 212 Ended
Comments: Company will be acquired in the near future.
tone7ate9 12/30/2011 3 months $0.50 $1.60 +218.66% 218 Ended
Comments: Way oversold! They have other FDA approved products.
sumitha.ragh 03/15/2011 3 months $1.79 $1.60 -10.61% -10 Ended
Comments: Upcoming product launch will be successful
bill_14 03/11/2011 1 Year $1.89 $1.60 -15.34% -15 Ended
Comments: Industry sector growing or poised for growth
Ashton_2 03/08/2011 1 Year $1.96 $1.60 -18.37% -18 Ended
Comments: Upcoming product launch will be successful
jdg0012 02/12/2011 3 months $2.31 $1.60 -30.74% -30 Ended
Comments: This stock is undervalued
henry_16 02/07/2011 1 month $2.13 $1.60 -24.88% -24 Ended
Comments: Upcoming product launch will be successful

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.